Wu X, Huang H, Li M, Wang Y, Wu X, Wang Q, Shen J, Xiao Z, Zhao Y, Du F, Chen
Y, Yang Y, Zhao Q, Zeng J, He Y, Xiao J, Excessive consumption of the sugar rich
longan fruit promoted the development of nonalcoholic fatty liver disease via mediating
gut dysbiosis, Food Frontiers, 2022 Accept.
Yang Y, Li M, Wang Q, Huang H, Zhao Y, Du F, Chen Y, Shen J, Luo H, Zhao Q, Zeng J, Li W, Chen M, Li X, Wang F, Sun Y, Gu L, Xiao Z, Wu X. Pueraria lobata
starch regulates gut microbiota and alleviates high-fat high-cholesterol diet induced
non-alcoholic fatty liver disease in mice, Food Research International. 2022 May.
Zhao Y, Guo S, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Chen M, Li X, Li W, Gu L, Sun Y, Wen Q, Li J, Xiao Z. VEGF/VEGFR-Targeted Therapy and Immunotherapy in
Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment. International
Journal of Biological Sciences. 2022 May 29.
Dai Y, Yang L, Sakandar A, Zhang D, Du F, Zhang X, Zhao Y, Wang J, Zhang Z, Wu
X, Li M, Ling X, Yu L, Dong L,Shen J, Xiao Z and Wen Q. Vemurafenib inhibitsimmune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to
suppress breast cancer. Front. Oncol. 2022 Nov 17.
Chen Y, Yang Q, Xu J, Tang L, Zhang Y, Du F, Zhao Y, Wu X, Li M, Shen J, Ding R, Cao H, Li W, Li X, Chen M, Wu Z, Cho CH, Du Y, Wen Q, Xiao Z. PROTACs in
Gastrointestinal Cancers. Mol Ther - Oncolytics. 2022 Oct 31.
Zhao Y, Deng J, Rao S, Guo S, Shen J, Du F, Wu X, Chen Y, Li M, Chen M, Li X, Li
W, Gu L, Sun Y, Zhang Z, Wen Q, Xiao Z, Li J. Tumor Infiltrating Lymphocyte (TIL)
Therapy for Solid Tumor Treatment: Progressions and Challenges. Cancers (Basel). 2022 Aug 27.
Chen Y, Zheng A, Zhang Y, Xiao M, Zhao Y, Wu X, Li M, Du F, Chen Y, Chen M, Li
W, Li X, Sun Y, Gu L, Xiao Z and Shen J. Dysregulation of B7 family and its
association with tumor microenvironment in uveal melanoma. Front. Immunol. 2022
Oct 14.
Xiang S, Li J, Shen J, Zhao Y, Wu X, Li M, Yang X, Kaboli PJ, Du F, Zheng Y, Wen Q, Cho CH, Yi T, Xiao Z. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Front Immunol. 2021 Apr 7;12:653836.
Zhao Q, Jiang Y, Xiang S, Kaboli PJ, Shen J, Zhao Y, Wu X, Du F, Li M, Cho CH, Li J, Wen Q, Liu T, Yi T, Xiao Z. Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons. Front Immunol. 2021 Mar 30;12:658753.
Ma Y, Zhang Y, Xiang J, Xiang S, Zhao Y, Xiao M, Du F, Ji H, Kaboli PJ, Wu X, Li M, Wen Q, Shen J, Yang Z, Li J, Xiao Z. Met agenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer. Front Cell Infect Microbiol. 2021 Feb 26;11:599734.
Zhao Q, Guo J, Zhao Y, Shen J, Kaboli PJ, Xiang S, Du F, Wu X, Li M, Wan L, Li X, Wen Q, Li J, Zou C, Xiao Z. Comprehensi ve assessment of PD-L1 and PD-L2 dysregulation in gastrointestinal cancers. Epigenomics. 2020 Dec;12(24):2155-2171.
Xiang S, Ma Y, Shen J, Zhao Y, Wu X, Li M, Yang X, Kaboli PJ, Du F, Ji H, Zheng Y, Li X, Li J, Wen Q, Xiao Z. m5C RNA Meth ylation Primarily Affects the ErbB and PI3K-Akt Signaling Pathways in Gastrointestinal Cancer. Front Mol Biosci. 2020 Dec7;7:599340.
Jabbarzadeh Kaboli P, Afzalipour Khoshkbejari M, Mohammadi M, Abiri A, Mokhtarian R, Vazifemand R, Amanollahi S, Yazdi Sani S, Li M, Zhao Y, Wu X, Shen J, Cho CH, Xiao Z. Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer – contradictory effects and future perspectives. Biomed Pharmacother. 2020 Jan;121:109635.
Jabbarzadeh Kaboli P, Salimian F, Aghapour S, Xiang S, Zhao Q, Li M, Wu X, Du F, Zhao Y, Shen J, Cho CH, Xiao Z. Akt-targ eted therapy as a promising strategy to overcome drug resistance in breast cancer - A comprehensive review from chemotherapy to immunotherapy. Pharmacol Res. 2020 Jun;156:104806.
Jin J, Wu X, Yin J, Li M, Shen J, Li J, Zhao Y, Zhao Q, Wu J, Wen Q, Cho CH, Yi T, Xiao Z. Identification of genetic mutations in cancer: challenge and opportunity in the new era of targeted therapy, Frontiers in Oncology. 2019, Accepted.
Zhao Y, Zhao Q, Kaboli PJ, Shen J, Li M, Wu X, Yin J, Zhang H, Wu Y, Lin L, Zhang L, Wan L, Wen Q, Li X, Cho CH, Yi T, Li J, Xiao Z. m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer. Translational Oncology, 2019, Accepted.
Xu Z, Wang Y, Xiao Z, Zou C, Wu D, Yu S, Chan FL. Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer. Oncogene, 2018, Accepted
Zhao Y, Chen B, Shen J, Wan L, Zhu Y, Yi T, Xiao Z. The Beneficial Effects of Quercetin, Curcumin and Resveratrol in Obesity, Oxidative Medicine and Cellular Longevity, 2017. 2017：0~1459497.
Xu Z, Shen J, Wang H, Yi T, Yu Y, Zhu Y, Chen B, Chen J, Li L, Li M, Zuo J, Jiang H, Zhou D, Luan J, Xiao Z. Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer. OncoImmunology. 2016, 5(8):e1207841.
Xiao Z, Shen J, Zhang L, Li L, Li MX, Hu W, Li ZJ, Cho CH. The roles of histone demethylase UTX and JMJD3 (KDM6B) in cancers: current progress and future perspectives. Curr Med Chem. 2016, 23(32):3687-96.
Shen J, Xiao Z, Wu KK, Wang M, To KF, Chen Y, Yang W, Li S, Shin V, Tong J, Kang W, Zhang L, Li M, Wang L, Lu L, Chan RLY, Wong SH, Yu J, Chan MTV, Chan FKL, Sung JJY, Cheng ASL, Cho CH. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. Cancer Res. 2014, 75(4):1-12.
Xiao Z, Li CH, Chan SL, Xu F, Feng L, Wang Y, Jiang JD, Sung JJ, Cheng CH, Chen Y. A small molecule modulator of the tumor suppressor miRNA-34a inhibits the growth of hepatocellular carcinoma. Cancer Res. 2014, 74(21):6236-47.
Li CH, To KF, Tong JH, Xiao Z, Xia T, Lai PB, Chow SC, Zhu YX, Chan SL, Marquez VE, Chen Y. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Gastroenterology. 2013, 144(5):1086-97.
